Clinical trials
Angina Pectoris trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 2 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 2 |
| I.M. Sechenov First Moscow State Medical University | 2 |
| Amarin Pharma Inc. | 1 |
| Bayer | 1 |
| Biotronik Russia | 1 |
| Burnasyan Federal Medical Biophysical Center | 1 |
| Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc. | 1 |
| Cardium Therapeutics | 1 |
| Cytokinetics | 1 |
| International Foundation for Development of Medical Science and Education Healthy Heart | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Angina Pectoris | 14 |
| Coronary Artery Disease | 8 |
| Myocardial Ischemia | 5 |
| Cardiovascular Diseases | 3 |
| Heart Diseases | 3 |
| Acute Coronary Syndrome | 2 |
| Angina, Stable | 2 |
| Chest Pain | 2 |
| Myocardial Infarction | 2 |
| Peripheral Arterial Disease | 2 |
Trials
Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.